RTTNews | Oct 5, 2021 08:38AM EDT

08:37 Tuesday, October 5, 2021 (RTTNews) - Zymeworks : First Patient Dosed In Phase 1b/2 Trial Of Zanidatamab & Evorpacept In Breast Cancer And Other Solid Tumors

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved